Cosentyx sensoready 150 MG penml
Ended Awarded Last action
- Contract number
- SPE2DR26FNR3T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,421
Award facts
- Contract value 100% obligated
- $28,420.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,420.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx Sensoready 150 mg/pen/ml, a pharmaceutical product used in the treatment of inflammatory conditions. The contract is non-set-aside and competitively awarded, with an ultimate completion date of January 12, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent organization Cencora, Inc. (doing business as AmerisourceBergen) holding the overarching authority. This delivery order is a child contract issued under a larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical.
This delivery order falls under Cencora, Inc.'s significant $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical, which extends through December 31, 2031. That primary IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of pharmaceutical products, medical supplies, specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs worldwide. The contract structure demonstrates AmerisourceBergen's established capability as a critical pharmaceutical distributor serving federal medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm fixed-price structure and competitive award process reflect the company's proven ability to meet federal procurement requirements efficiently.
Quick answers
Who was awarded contract SPE2DR26FNR3T?
SPE2DR26FNR3T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FNR3T worth?
The government has obligated $28,421 on SPE2DR26FNR3T.
Is contract SPE2DR26FNR3T an order under another contract?
Yes. SPE2DR26FNR3T is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNR3T competed?
The extent of competition for SPE2DR26FNR3T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award